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Ca2+ signals mediated by bradykinin type 2 receptors in
normal pancreatic stellate cells can be inhibited by specific
Ca2+ channel blockade
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Key points
 Bradykinin may play a role in the autodigestive disease acute pancreatitis, but little is known
about its pancreatic actions.
 In this study, we have investigated bradykinin-elicited Ca2+ signal generation in normal mouse
pancreatic lobules.
 We found complete separation of Ca2+ signalling between pancreatic acinar (PACs) and stellate
cells (PSCs). Pathophysiologically relevant bradykinin concentrations consistently evokedCa2+
signals, via B2 receptors, in PSCs but never in neighbouring PACs, whereas cholecystokinin,
consistently evoking Ca2+ signals in PACs, never elicited Ca2+ signals in PSCs.
 The bradykinin-elicited Ca2+ signals were due to initial Ca2+ release from inositol
trisphosphate-sensitive stores followed by Ca2+ entry through Ca2+ release-activated channels
(CRACs). The Ca2+ entry phase was effectively inhibited by a CRAC blocker.
 B2 receptor blockade reduced the extent of PAC necrosis evoked by pancreatitis-promoting
agents and we therefore conclude that bradykinin plays a role in acute pancreatitis via specific
actions on PSCs.
Abstract Normal pancreatic stellate cells (PSCs) are regarded as quiescent, only to become
activated in chronic pancreatitis and pancreatic cancer. However, we now report that these cells in
their normal microenvironment are far from quiescent, but are capable of generating substantial
Ca2+ signals. We have compared Ca2+ signalling in PSCs and their better studied neighbouring
acinar cells (PACs) and found complete separation of Ca2+ signalling in even closely neigh-
bouringPACs andPSCs. Bradykinin (BK), at concentrations corresponding to the slightly elevated
plasma BK levels that have been shown to occur in the auto-digestive disease acute pancreatitis
in vivo, consistently elicited substantial Ca2+ signals in PSCs, but never in neighbouring PACs,
whereas the physiological PAC stimulant cholecystokinin failed to evoke Ca2+ signals in PSCs.
The BK-induced Ca2+ signals were mediated by B2 receptors and B2 receptor blockade protected
against PAC necrosis evoked by agents causing acute pancreatitis. The initial Ca2+ rise in PSCs
was due to inositol trisphosphate receptor-mediated release from internal stores, whereas the
sustained phase depended on external Ca2+ entry through Ca2+ release-activated Ca2+ (CRAC)
channels. CRAC channel inhibitors, which have been shown to protect PACs against damage
caused by agents inducing pancreatitis, therefore also inhibit Ca2+ signal generation in PSCs and
this may be helpful in treating acute pancreatitis.
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Introduction
It has been known for more than 40 years that pancreatic
enzyme secretion is regulated by Ca2+ signals in the
pancreatic acinar cells (PACs) and that the primary event is
acetylcholine- (ACh) or cholecystokinin- (CCK) elicited
intracellular Ca2+ release followed by Ca2+ entry (Case
& Clausen, 1973; Matthews et al. 1973; Kondo & Schulz,
1976; Petersen & Ueda, 1976). The ACh-evoked intra-
cellular Ca2+ release is mediated by inositol trisphosphate
(IP3) (Streb et al. 1983; Wakui et al. 1990), whereas
the CCK-elicited Ca2+ release is mediated by nicotinic
acid adenine dinucleotide phosphate (Cancela et al. 2000;
Gerasimenko et al. 2015). As high K+ depolarization of
the PAC membrane does not evoke enzyme secretion or
Ca2+ movement (Argent et al. 1971;Matthews et al. 1973),
the Ca2+ entry does not occur through voltage-gated
channels (Petersen, 1992), but is due to opening of
Ca2+ release-activated Ca2+ (CRAC) channels (Parekh
& Putney, 2005; Gerasimenko et al. 2013). The acinar
Ca2+ signals also regulate acinar fluid secretion via
Ca2+-activated Cl− and K+ channels (Petersen, 1992;
Park et al. 2001). However, the major component of
pancreatic fluid secretion is contributed by the ducts
and this is regulated by secretin-elicited intra-ductal
cyclic AMP formation controlling cystic fibrosis trans-
membrane conductance regulator (CFTR) channels
(Argent, 2006), whose openings are also regulated by the
Cl− concentration in the luminal fluid (Broadbent et al.
2015).
The often fatal human disease acute pancreatitis, in
which the pancreas digests itself and its surroundings,
is initiated by excessive intracellular Ca2+ release in the
PACs followed by excessive Ca2+ entry, mostly elicited
by combinations of alcohol and fatty acids or by bile
acids (Petersen & Sutton, 2006; Gerasimenko et al. 2014).
Pancreatitis-inducing agents also inhibit ductal fluid and
bicarbonate secretion, exacerbating the disease (Pallagi
et al. 2011; Maleth et al. 2015).
We have extensive knowledge of the mechanisms
generating Ca2+ signals in the PACs, which has been
built up over many decades (Petersen & Tepikin, 2008;
Gerasimenko et al. 2014). In contrast, the more recently
discovered pancreatic stellate cells (PSCs) (Watari et al.
1982), located in the peri-acinar space – with elongated
processes around the base of the acinus – have received
much less attention and it has essentially been the
functional properties of cultured cells that have been
investigated (Apte et al. 1998, 2012; Bachem et al.
1998; Wells & Crawford, 1998). The prevailing, and so
far unchallenged, view has been that normal PSCs are
quiescent and the focus in all published studies has been
on the activation of PSCs and their role – in the activated
state – in chronic pancreatitis and pancreatic cancer
(Bachem et al. 1998; Wells & Crawford, 1998; Sherman
et al. 2014). Activation of PSCs – during pancreatic injury
or culturing of quiescent PSCs – induces proliferation
as well as secretion of extracellular matrix components,
thereby playing an important role in the fibrosis that
occurs in chronic pancreatitis and pancreatic cancer
(Sherman et al. 2014). Work on the so-called quiescent
PSCs in culture has shown that they can generate sub-
stantial cytosolic Ca2+ signals in response to stimulation
with high concentrations of the blood pressure-lowering
nona-peptide bradykinin (BK) and some other substances
(Won et al. 2011).
BecauseBKhas long been knownas an important player
in inflammatory disease, including acute pancreatitis
(Ryan et al. 1964; Hirata et al. 2002), we have now
investigated BK-induced Ca2+ signal generation, and its
underlying mechanism, in normal PSCs in their normal
microenvironment. We find that normal PSCs are much
more sensitive to BK than PSCs in culture, generating sub-
stantial Ca2+ signals in response to a BK concentration as
low as 100 pM, with maximal effect at 1 nM, orders of
magnitude lower than what has been observed in cultured
cells (Won et al. 2011). This has important implications,
as the threshold for activating normal PSCs (100 pM)
is close to the normal plasma level of BK (40–70 pM)
(Blais et al. 1999; Hirata et al. 2002) and any increase
in the plasma or tissue BK levels, which occurs under
several conditions – including acute pancreatitis and use
of angiotensin-converting-enzyme (ACE) inhibitors (Liu
et al. 1997; Blais et al. 1999; Tsutsumi et al. 1999; Hirata
et al. 2002; Su, 2014) – would therefore elicit Ca2+
signals in PSCs. We have explored the Ca2+ signalling
events and their underlying mechanisms in normal PSCs
and show that BK activates bradykinin type 2 (B2)
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receptors, which causes primary Ca2+ release from inter-
nal stores. This effect can be abolished by phospholipase C
inhibition or blockade of IP3 receptors (IP3Rs). Following
the initial intracellular Ca2+ release, there is opening of
conventional CRAC channels (Parekh & Putney, 2005;
Parekh, 2010) and we show that a recently employed
CRAC channel inhibitor, which was protective against
the destruction of PACs evoked by agents inducing
pancreatitis (Gerasimenko et al. 2013, 2014), also reduces
BK-induced Ca2+ signal generation in PSCs. We show
that B2 receptor blockade protects against the necrosis
evoked by pancreatitis-inducing agents and suggest that
the protective effect of CRAC channel blockade against
pancreatitis may in part be due to inhibition of Ca2+
signal generation in PSCs. Overall, our new data indicate
that the so far generally accepted notion of normal PSCs
being quiescent is potentially misleading as they are in
fact exquisitely sensitive to relatively small changes in BK
concentrations found in vivo.
Methods
Ethical approval
All procedures were carried out in accordance with UK
Home Office regulations.
Preparation of pancreatic lobules
Pancreatic lobules and big clusters were isolated from
the pancreas of adult C57Bl/6 male mice. Animals
were killed according to UK Schedule 1 regulations.
The pancreas was rapidly dissected, transferred to
collagenase Na-Hepes-based solution (Sigma, Poole, UK)
and incubated at 37°C for 5–6 min. After digestion, the
tissue was kept in Na-Hepes-based extracellular media,
containing (inmM):NaCl, 140; KCl, 4.7;Hepes (KOH), 10;
MgCl2, 1; glucose 10; CaCl2 1; pH 7.2. Pancreatic lobules
were then incubated with fluorescent dye following the
manufacturer’s description. All experiments were carried
out with freshly prepared pancreatic lobules, attached
to the coverslip of the perfusion chamber at room
temperature (23°C). Penetration of various substances
deep into the pancreatic lobule was highly dependent
on the distance from the surface (Fig. 1A, B). It was
therefore necessary, in several cases, to use relatively high
concentrations (up to 5-fold higher than would have been
necessary in experiments on isolated cells or very small
cell clusters) and relatively long pre-incubation times.
[Ca2+] measurements in intact cells
Intact cells were loaded with 5 µM Fluo-4 acetoxymethyl
ester (AM), for 10 min at room temperature. Cells were
transferred to a flow chamber and perfused with the
Na-Hepes-based extracellular solution as described above.
Cells were visualized using a Leica SP5 MPII two-photon
confocal microscope, with a 63× 1.2 NA objective lens.
Fluo-4 was excited with a 488 nmAr laser, at 1–4% power,
and emitted light was collected at 510–580 nm. Generally,
a series of imageswas recorded at 512×512pixel resolution
(at a speed of 0.3 frames s−1), and analysed using
Leica Confocal Software (Leica, Mannheim, Germany).
Fluorescence signals were plotted as F/F0 (F0 is the initial
level of fluorescence). Statistical analysis was performed
using ANOVA or Student’s t-test.
Measurements of necrosis level in pancreatic lobules
Pancreatic lobules were exposed to 350 mM ethanol, or
500 µM palmitoleic acid ethyl ester (POAEE) or 0.5%
sodium choleate for 2 h in the presence or absence of
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Figure 1. Pancreatic lobule preparation: penetration of applied substances into deep layers
Experiment illustrating the difficulties of attaining the full concentration level deep inside the pancreatic tissue
of substances applied to the surface of a lobule. A, [Ca2+]i traces obtained from PACs at different depths from
the surface of the lobule (signposted by the colour coding shown). Responses to ACh (10 µM), carbachol (CCh)
(10 µM) and CCK (10 nM) are shown. B, transmitted light image of the lobule from which the recordings shown
in A were obtained. The different recording positions are indicated using the colour coding shown in A.
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0.5 µM or 10 µM WIN 64338. Ethanol- or bile-induced
pancreatic necrosis was visualized by staining the lobules
withpropidiumiodide (PI) andcomparedwith the control
necrosis level (without any treatment). Simultaneously
lobules were stained with the nuclear dye Hoechst 33342
to enable cell counting. Both stainings were performed
according to the manufacturer’s protocols. Fluorescence
of Hoechst 33342 and PI was recorded using confocal
microscopy, with a 63× 1.2 NA objective lens (excitations
355 and 543 nm; and emissions 390–480 and 570–650 nm,
respectively).
Immunocytochemistry
Immunocytochemistry in pancreatic lobules and big
clusters was performed as described by Lur et al.
(2009) with some modifications. Following blocking with
1% BSA and 10% goat serum, the isolated pancreatic
lobules were incubated for 1 h at room temperature
with primary antibody (CCK-AR) in 5% goat serum in
PBS. The pancreatic lobules were subsequently incubated
with CruzFluor (CFL) 594-conjugated secondary anti-
body for 30 min at room temperature. Cells were
attached to the glass coverslips covered with poly-L-lysin.
For immunochemical staining with desmin antibody,
pancreatic lobules were fixed with 4% paraformaldehyde
followed by permeabilization with Triton X100, blocking
and incubation with primary (desmin) and then with
secondary (CFL) antibodies as described above.
Reagents
Chemicals, unless otherwise indicated, were obtained
from Sigma or Calbiochem (Merck, UK). BK, R-715
and WIN64338 were purchased from Tocris Biosciences
(Bristol, UK). Fluo-4 AM, PI and Hoechst 33342 were
purchased from Invitrogen (Life Technologies, Carlsbad,
CA, USA). Antibodies against CCK-A (CCK1) receptor
(sc-16172), desmin antibody (sc-7559) and donkey
anti-goat IgG-CFL 594 (sc-362275) were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
Results
Separate Ca2+ signalling events in neighbouring PSCs
and PACs
It has been shown that desmin is a good marker for PSCs
(Apte et al. 1998) and we found that immunochemical
staining with desmin antibody identified small elongated
cells situated at the periphery of the dominant acinar cells
(Fig. 2A–C). The presence of vitamin A in lipid droplets is
another characteristic of PSCs (Bachem et al. 1998) andwe
could visualize this by intrinsic multiphoton fluorescence
(Fig. 2D, E).
Cells situated in the position characteristic of
desmin-containing cells (Fig. 2C) took up the
Ca2+-sensitive fluorescent probe Fluo-4muchmore avidly
thanPACs (Fig. 3A–C). In large lobules stainedwithFluo-4
(Fig. 3A, B), it was often possible to observe PSCs as bright
‘strings’, whereas in smaller cell clusters, they typically
appeared as individual bright cells at the periphery of
acinar units (Fig. 3Ca).
Cultured PSCs produce cytosolic Ca2+ signals in
response to a micromolar concentration of BK (Won et al.
2011). In our experiments, normal PSCs in their normal
micro-environment typically responded to a short-lasting
exposure to a much lower BK concentration (1 nM)
with a sharp transient rise in [Ca2+]i, quickly followed
by a longer lasting (plateau) phase of elevated [Ca2+]i
(Figs 3Cb and 4A). Neighbouring PACs never displayed
DAPI Desmin-CFL 594 
A B C
10 μm 10 μm 10 μm 
Vitamin A
20.0 μm 20.0 μm
D E
Figure 2. Identification of PSCs in
lobule preparation
A, localization of nuclei is shown by
staining with DAPI. B, staining with desmin
antibody, visualized with conjugated
secondary antibody IgG-CruzFluor 594 (CFL
594). C, overlay of transmitted light image
with DAPI and desmin antibody (n = 6). D,
visualization of lipid droplets containing
vitamin A by multiphoton intrinsic
fluorescence (n = 6). E, transmitted light
image of the pancreatic lobule shown in D.
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any change in [Ca2+]i during the BK-induced PSC Ca2+
signals (>100 experiments) (Figs 3Cb and 4A), indicating
lack of functional BK receptors on PACs and lack of
direct communication between neighbouring PACs and
PSCs. The typical, and physiologically important, PAC
stimulants ACh and CCK evoked Ca2+ signals in PACs
(Petersen & Tepikin, 2008), which were not transmitted
to the neighbouring PSCs (n = 14 and 17, respectively)
(Figs 3Cb and 4A). ATP (100µM) elicited Ca2+ signals in a
proportion of PSCs (41 of 107 cells), but failed to do so in
many others (Fig. 4A). When ATP evoked a [Ca2+]i rise in
a PSC, it was never transmitted to the neighbouring PAC
(Fig. 4A).
Phillips et al. (2010) have suggested that CCK-evoked
release of ACh from PSCs could in turn activate PACs and
they proposed that this could be the normal mechanism
for CCK-elicited secretion from human PACs. However,
we did not find any evidence for this hypothesis as CCK
never evoked any Ca2+ signals in PSCs in our preparations
(n = 17; at [CCK] = 10 nM) and Ca2+ signals in PSCs
consistently failed to be transmitted to neighbouring PACs
(Fig. 4A). Furthermore, although a fluorescent antibody
to CCK1 receptors clearly identified the presence of CCK1
receptors on PACs, it failed to do so with regard to PSCs
(four experiments) (Fig. 4B).
BK evokes Ca2+ signals in PSCs at pico- and low
nanomolar concentrations
It seemed important to explore the levels of BK needed to
evoke Ca2+ signals (Fig. 5) in relation to what is known
about BK concentrations in plasma. From measurements
in humans and rats, it is known that normal plasma
BK concentrations are in the range 40–70 pM (Blais
et al. 1999; Hirata et al. 2002). However, in a bile duct
obstruction model of acute pancreatitis induced in rats, it
has been shown that the BK plasma concentration rose to
140 pM (Hirata et al. 2002). As the BK release in acute
pancreatitis primarily comes from the pancreas, the local
(intra-pancreatic) BK levels could be higher (Ryan et al.
1964; Schachter, 1969). We found that a BK concentration
as low as 100 pM (n = 14) could elicit PSC Ca2+ signals
and that maximal responses were obtained at 1 nM (n= 9,
in the series of experiments represented by Fig. 5C). Over-
all, in the course of this investigation, BK responses to
1 nM have been observed in >100 experiments. At the
low BK concentrations we used, there was no sign of
desensitization (Fig. 5A). Within the time frame of our
protocols, the [Ca2+]i elevation was maintained as long as
the stimulus was maintained (n = 19) (Fig. 5A). It would
therefore appear that normalPSCs are sufficiently sensitive
b
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Figure 3. Complete separation of Ca2+
signalling in neighbouring PSCs and
PACs
A, transmitted light image of live mouse
pancreatic lobule. B, fluorescence image of
the same lobule (Fluo-4). The small
elongated cells with long processes (PSCs)
are much better loaded with Fluo-4 than
the larger PACs. C, [Ca2+]i measurements
in neighbouring PSCs and PACs in a small
cell cluster. a, fluorescence image of the
live small cell cluster from which recordings
were made. A highly fluorescent PSC is
signposted by the white arrow outlined in
red, whereas the much less fluorescent
neighbouring PAC is signposted by the
white arrow with blue outline. b, [Ca2+]i
traces from the two cells signposted in a.
Red trace from the PSC and blue trace
from the PAC. BK (1 nM) evokes a typical
biphasic Ca2+ signal in the PSC but not in
the neighbouring PAC, whereas ACh
(10 µM) and CCh (10 µM) evoke Ca2+
signals in the PAC but not in the PSC.
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to BK to be able to sense relatively small increases in the
surrounding BK level.
Although thePSCs inour lobule preparationweremuch
more sensitive to BK than those previously studied in
culture (Won et al.2011), theydohave somecharacteristics
in common with quiescent PSCs in culture which, unlike
activated PSCs, do not respond to trypsin and thrombin.
As seen in Fig. 6 there was no response to thrombin
(n = 6) (Fig. 6A) or trypsin (n = 18) (Fig. 6B) in cells
that responded to BK with a clear Ca2+ signal.
The BK-elicited Ca2+ signals in PSCs are due to
activation of B2 receptors
The BK receptor sub-type responsible for generating Ca2+
signals in PSCs has not previously been investigated.
We employed the B2 receptor blocker WIN64338 (Hu
et al. 2004) and showed that this agent reversibly blocked
BK-elicited Ca2+ signal generation (n = 27) (Fig. 7A).
In contrast, the B1 receptor blocker R-715 (Abdouh
et al. 2008) failed to inhibit BK-induced Ca2+ signalling
(n = 8) (Fig. 7B). Furthermore, the specific B1 agonist
Sar-des-Arg-BK did not evoke any changes in [Ca2+]i of
PSCs (n = 8) (Fig. 7C). It would appear that the plateau
phase of the BK-induced response to some extent depends
on continued B2 receptor activation, because application
of WIN64338 immediately after the initial BK-elicited
Ca2+ spike shortened the duration of the plateau phase
(Fig. 7D).
As a previous study showed that BK levels increase
in acute pancreatitis and that blockade of B2
receptors attenuated the cellular changes underlying the
development of acute pancreatitis evoked by obstruction
of the pancreatico-biliary duct in rats (Hirata et al. 2002),
our results raise the possibility that B2 receptor-mediated
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Figure 4. BK, but not CCK, evokes Ca2+
signal in PSCs
A, simultaneous [Ca2+]i traces from two PSCs
and one PAC in the same cell cluster. CCK
(10 nM) only evoked a Ca2+ signal in the PAC
but not in the two PSCs, whereas BK (1 nM)
elicited Ca2+ signals in both PSCs but not the
PAC. ATP (100 µM) evoked a response in one
PSC but not in the other and not in the PAC. B,
immunostaining of CCK receptors in a
pancreatic lobule. i, a PSC identified by bright
staining with Fluo-4. The response to BK (5 nM)
is shown in the inset (amplitude scale bar 1
F/F0, time scale bar 2 min). ii, visualization of
CCK1 receptors by antibody against the CCK1
receptor with subsequent application of
secondary antibody (CFL 594). iii, overlay of i
and ii showing the localization of CCK1
receptors on the surface of PACs, but not the
PSC.
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Ca2+ signals in PSCs contribute to the negative outcome
of this disease. We therefore tested whether B2 receptor
blockade could protect against cellular changes relevant
to the development of acute pancreatitis, which is
most frequently related to alcohol abuse or biliary
disease (Petersen & Sutton, 2006). In alcohol-related
acute pancreatitis, the pancreas is exposed not only to
alcohol, but also to fatty acid ethyl esters (non-oxidative
combinations of alcohol and fatty acids), which have been
shown to be particularly effective releasers of intracellular
Ca2+ (Criddle et al. 2006; Gerasimenko et al. 2009).
In biliary disease, the pancreas will be exposed to high
concentrations of bile acids, which have also been shown
to be effective liberators of stored Ca2+ (Voronina et al.
2002; Gerasimenko et al. 2006). We therefore tested the
effects of B2 receptor blockade on the level of necrosis
elicited by alcohol, POAEE and a bile acid mixture. As
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Figure 5. BK concentration–response relationship
A, [Ca2+]i trace from PSC showing that 5 nM BK evokes maximal
sustained response, which is not enhanced by increasing the BK
concentration to 50 nM. B, family of [Ca2+]i traces all obtained from
the same PSC, showing responses to BK concentrations from 0.1 to
3 nM. C, BK concentration–response (amplitude of plateau phase)
relationship. Half-maximal response is at a BK concentration of
200 pM. A very similar relationship was obtained for the initial peak
response.
seen in Fig. 8, B2 receptor blockade markedly reduced
the extent of acinar cell necrosis induced by either a
high alcohol concentration (350 mM), POAEE (500 µM)
or bile acids (0.5% sodium choleate: a crude ox bile
extract which contains the sodium salts of taurocholic,
glycocholic, deoxycholic and cholic acids).
BK-elicited Ca2+ signals in PSCs are primarily due to
release of Ca2+ from internal stores, but is followed
by store-operated Ca2+ entry
As shown in Figs 3–5, the BK-elicited Ca2+ signals consist
of a brief transient rise in [Ca2+]i, followed by a prolonged
plateau phase of elevated [Ca2+]i. Acute removal of
externalCa2+ didnot reduce the initial phaseofBK-evoked
Ca2+ signals, but eliminated the following plateau phase
(Fig. 9A, B). Re-admission of Ca2+ resulted in a trans-
ient increase in [Ca2+]i and enabled a subsequent BK
application to evoke a normal response (Fig. 9A, B). We
tested the ability of PSCs to generate store-operated Ca2+
entry, by using the now ‘classical’ protocol for assessing
this phenomenon (Fig. 9C), employing cyclopiazonic acid
(CPA) to block the Ca2+ pumps in the endoplasmic
reticulum(ER).As shown inFig. 9B andC, re-admissionof
external Ca2+ after a period of external Ca2+ deprivation,
and BK stimulation, resulted in a transient rise in [Ca2+]i,
but, if the Ca2+ re-admission occurred after and during a
period of continuedERCa2+ pump inhibition, the [Ca2+]i
elevation was sustained (Fig. 9C). In this situation, Ca2+
entering store-operated Ca2+ channels cannot be taken up
into the ER, but will only slowly be extruded by the plasma
membrane Ca2+ pumps.
We tried to block the store-operated Ca2+ entry
pharmacologically. 2-APB, a well-known, but relatively
unspecific, blocker of CRAC channels (Parekh & Putney,
2005), abolished BK-induced Ca2+ signal generation
(Fig. 9D), which may be due to blockade of IP3Rs (Ma
et al. 2000). We also used a more specific CRAC channel
blocker, GSK-7975A, which has recently been shown to
block CRAC channel currents in PACs (Gerasimenko
et al. 2013). In these experiments, we were able to show
that GSK-7975A reversibly blocked the plateau phase of
the BK-induced [Ca2+]i elevation, without affecting the
initial spike (n= 9)(Fig. 9E). GSK-7975A also blocked the
Ca2+ entry normally occurring when external Ca2+ was
re-admitted after a period of external Ca2+ deprivation
(n = 14) (Fig. 9F).
Finally, we examined the mechanism underlying the
initial Ca2+ spike in response to BK stimulation. Having
established that it is due to release of Ca2+ from internal
stores (Fig. 9A), we tested the hypothesis that this Ca2+
liberation occurs through IP3Rs. It is now well stablished
that caffeine inhibits opening of IP3Rs (Wakui et al. 1990;
Ehrlich et al. 1994; Foskett et al. 2007). As seen in Fig. 9G,
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caffeine did reversibly block BK-elicited Ca2+ signalling
(n = 29). BK probably activates phospholipase C, as
U73122 (Bleasdale et al. 1990; Smith et al. 1990) blocked
the ability of BK to evoke Ca2+ signals (n = 14) (Fig. 9H).
Discussion
Our results demonstrate for the first time that BK, in
concentrations close to those measured in normal plasma
(Blais et al. 1999; Hirata et al. 2002), elicits substantial
cytosolic Ca2+ signals in normal PSCs in their normal
micro-environment and therefore cast doubt on the
hitherto prevailing concept of the quiescent PSC (Apte
et al. 1998, 2012; Sherman et al. 2014).
Given that an important role for BK in the development
of acute pancreatitis was proposed by Ryan et al. (1964),
that there is an increase in the plasma level of BK in acute
pancreatitis (Hirata et al. 2002) and that a number of
studies have shown that pharmacological blockade of B2
receptors is helpful in suppressing the cellular changes
in several pancreatitis disease models (Griesbacher &
A
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Figure 6. Thrombin and trypsin do not evoke Ca2+ signals in PSCs
A, thrombin (10 mU ml−1) does not evoke a Ca2+ signal in a PSC, but a subsequent BK application (1 nM) evokes
the usual response. B, trypsin (20 µM) fails to evoke a Ca2+ signal in a PSC, but a subsequent BK application (1 nM)
does so. The apparently delayed and somewhat smaller response to BK (although still within the normal range) in
B (as compared to A) is probably due to the fact that the cell cluster in this case was relatively large and the PSC
deep in the tissue (see Fig. 1).
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Figure 7. BK receptor pharmacology
A, the B2 receptor antagonist WIN64338 (10 µM) reversibly and completely blocked the BK- (1 nM) elicited Ca2+
signal, both peak (P < 0.000003) and plateau (P < 0.00004). B, the B1 receptor antagonist R-715 (10 µM) failed
to block the BK- (1 nM) elicited Ca2+ signal. C, the B1 receptor agonist Sar-des-Arg-BK (Sar-Des-BK) (1 µM) does
not evoke a Ca2+ signal in a PSC, whereas a subsequent application of BK (1 nM) elicits such a signal. D, the B2
receptor antagonist WIN64338 applied after the initial BK-evoked Ca2+ spike reduces markedly the length of the
plateau phase.
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Lembeck 1992; Griesbacher et al. 1993; Hoffmann et al.
1996; Bloechle et al. 1998; Hirata et al. 2002), it would
seem important to identify the target for the action of BK
in the pancreas and its mechanism of action.
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Figure 8. The extent of PAC death elicited by
pancreatitis-inducing agents is markedly reduced by B2
receptor blockade
A, treatment of pancreatic lobules with ethanol (350 mM) for 2 h at
room temperature increased significantly the percentage of PAC
necrosis from the control level of 5.47 ± 0.54% (n = 7) to 17 ± 1%
(n = 7) and this was significantly reduced to 7.85 ± 1.3% (n = 3) by
10 µM WIN64338 and to 7.84 ± 0.25% (n = 4) by 0.5 µM
WIN64338 (∗P = 0.0025 and ∗∗P = 0.00043, respectively, >1500
cells in each experimental group). B, treatment of pancreatic lobules
with POAEE (500 µM) for 2 h at room temperature increased
significantly the percentage of PAC necrosis from the control level of
5.46 ± 1.25% (n = 3) to 18.96 ± 1.76% (n = 3) and this was
reduced to 7.15 ± 0.67% (n = 3) by 0.5 µM WIN64338 (∗P = 0.003,
>990 cells in each experimental group). C, treatment of pancreatic
lobules with 0.5% sodium choleate for 2 h at room temperature also
increased significantly the percentage of PAC necrosis from the
control level of 6.1 ± 0.85% (n = 3) to 14 ± 1% (n = 3) and this
was significantly reduced to 7.8 ± 0.8% (n = 3) by 0.5 µM
WIN64338 (∗P = 0.0087, >1600 cells in each experimental group).
Necrosis was measured by staining of lobules with PI. Cell count was
performed using nuclear staining with Hoechst 33342. Bars
represent ±SEM.
Won et al. (2011) demonstrated that BK – in
high (micromolar) concentrations – evoked trans-
ient Ca2+ signals in quiescent and activated PSCs in
culture. We focused our attention on the effect of low
quasi-physiological concentrations of BK on normal PSCs
in their normal micro-environment, the mechanism of
action and its consequence. Our results show that whereas
BK consistently evokes bi-phasic Ca2+ signals in PSCs, it
consistently fails to do so even in closely neighbouring
PACs (Figs 3 and 4). We have therefore now identified
a specific cellular site for the action of BK, which may
partly or fully explain its importance in pancreatitis.
Furthermore, we have established that the BK-elicited
Ca2+ signals in PSCs are due to activation of B2 receptors,
providing a plausible explanation for the suppressive effect
of B2 blockade on the development of acute pancreatitis
(Griesbacher & Lembeck 1992; Griesbacher et al. 1993;
Hoffmann et al. 1996; Bloechle et al. 1998; Hirata et al.
2002). We have also shown that PAC necrosis elicited by
alcohol, POAEE or bile can be significantly reduced by B2
receptor blockade (Fig. 8).
We failed to observe any effects of CCK on PSCs,
although this hormone evoked its usual effect (Petersen &
Tepikin, 2008)onneighbouringPACs (Fig. 4A). Therefore,
our results do not provide support for the hypothesis that
CCK acting on PSCs will increase ACh secretion from
these cells, which in turn would activate PACs (Phillips
et al. 2010). We worked on normal mouse pancreatic
tissue, whereas Phillips et al. (2010) studied ACh secretion
from cultured human PSCs. Cultured PSCs clearly have
different properties from normal PSCs, because in the
normal mouse pancreas we have observed Ca2+ signal
generation in PSCs in response to 0.1 nM BK (Fig. 5),
whereas micromolar BK concentrations were required to
obtain such responses in cultured mouse PSCs (Won et al.
2011).With regard to themechanism of CCK action in the
human pancreas, the simplest hypothesis remains direct
action on PACs, as shown in isolated acinar cell clusters
from human pancreas (Murphy et al. 2008).
Although the initiating event elicited by
pancreatitis-inducing agents in PACs is Ca2+ release
from intracellular stores (Gerasimenko et al. 2014), we
have previously shown that the cellular damage only
happens if there is secondary Ca2+ entry from the
extracellular fluid (Raraty et al. 2000). We have recently
shown that the CRAC channel blocker GSK-7975A
markedly inhibits the store-operated Ca2+ entry that
sustains the [Ca2+]i elevation in PACs evoked by a
pancreatitis-inducing agent (Gerasimenko et al. 2013,
2014), a finding recently confirmed by Voronina et al.
(2015). We have previously shown that the CRAC channel
blockade by GSK-7975A provides effective protection
of the PACs from alcohol-related intracellular protease
activation and necrosis (Gerasimenko et al. 2013) and
these results have also very recently been confirmed in
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a study employing three different in vivo mouse models
of acute pancreatitis (Wen et al. 2015). The BK-elicited
Ca2+ signal generation in PSCs is due to initial release
of Ca2+ from internal stores followed by activation of
Ca2+ entry via store-operated channels. Our new results
show that GSK-7975A is also effective in reducing the
plateau phase of the BK-elicited [Ca2+]i elevation in
PSCs (Fig. 9E). Given that B2 receptor blockade protects
against pancreatitis-like cellular changes (Fig. 8), the
inhibitory effect of GSK-7975A on BK responses in PSCs
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Figure 9. Mechanisms of BK-elicited Ca2+ signal generation in PSCs
A and B, removal of external Ca2+ has no effect on the initial [Ca2+]i rise evoked by BK (1 nM, P > 0.7), but
abolishes the following plateau phase (P < 0.0003). Readmitting external Ca2+, in the absence of BK stimulation,
causes a transient rise in [Ca2+]i. C, when the SERCA pump inhibitor CPA (20 µM) is present, the [Ca2+]i rise upon
readmission of external Ca2+ is prolonged. D, 2-APB (100 µM) (IP3R antagonist and inhibitor of CRAC channels)
blocks Ca2+ signalling elicited by BK (1 nM). E, the CRAC channel blocker GSK-7975A (10 µM) reduces markedly
the plateau phase of the BK- (1 nM) elicited response (P < 0.0015). Washout of GSK-7975A partially restored
the response (P < 0.009). F, GSK (10 µM) does not inhibit the initial BK-elicited Ca2+ signal occurring in the
absence of external Ca2+ but prevents the [Ca2+]i rise normally occurring upon external Ca2+ readmission. G,
caffeine (30 mM) reversibly blocks BK- (1 nM) elicited Ca2+ signal. H, the phospholipase C inhibitor U73122 (30 µM)
abolished Ca2+ signal generation elicited by BK (1 nM), both peak (P < 0.0002) and plateau (P < 0.00001).
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may represent an additional potential benefit of treating
cases of severe acute pancreatitis with a CRAC channel
blocker. The inhibitory action of GSK-7975A on the
BK-induced plateau elevation of [Ca2+]i in PSCs may
well have contributed to the impressive protective effects
of this agent against acute pancreatitis in vivo (Wen et al.
2015).
Our new data are also relevant when considering the
now widespread use of ACE inhibitors in the treatment
of hypertension because ACE inhibitors inhibit the break-
down of BK, causing an increase in the tissue and plasma
levels of BK (Israili & Hall, 1992; Liu et al. 1997; Tsutsumi
et al. 1999; Su, 2014). Previous studies have shown that
use of ACE inhibitors is associated with a significantly
increased risk of developing acute pancreatitis (Tilkemeier
& Thompson, 1988; Eland et al. 2006), but themechanism
was unknown. As we have now shown that any increase
in the BK level will elicit Ca2+ signals in the PSCs via B2
receptors and that blockade of these receptors protects
against acute pancreatitis, it is likely that Ca2+ signal
generation in PSCs mediated by BK is at least in part
responsible for the increased risk of developing acute
pancreatitis during ACE inhibitor treatment.
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Translational Perspective
Our work indicates that bradykinin-elicited Ca2+ signals in pancreatic stellate cells may influence
negatively the outcome of acute pancreatitis. We tested the hypothesis that blockage of bradykinin
type 2 (B2) receptors would offer protection against the pancreatic acinar cell necrosis caused by
pancreatitis-inducing agents, such as alcohol, fatty acid ethyl esters or bile acids. The results showed
that specific B2 receptor blockade markedly reduced the extent of necrosis observed after treatment
with ethanol, POAEE or a mixture of bile acids. This suggests that B2 receptor blockade in the early
stage of acute pancreatitis may be helpful in reducing the severity of the disease. We also show that the
bradykinin-elicited sustained elevation of the cytosolic Ca2+ concentration in pancreatic stellate cells
can be inhibited by a specific inhibitor of Ca2+ release – activated Ca2+ (CRAC) channels. We have
recently shown that CRAC inhibition in PACs offers remarkable protection against necrosis induced
by fatty acid ethyl esters. In the intact pancreas, CRAC inhibition would reduce excessive Ca2+ signal
generation both in the acinar cells (brought about by, for example, fatty acid ethyl esters) and in the
stellate cells (brought about by bradykinin). Both effects would be beneficial. Our work therefore
indicates that combined treatment with a CRAC inhibitor and a B2 receptor – blocking agent should
be tested in vivo as a potentially useful therapy against acute pancreatitis.
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